DOLBY LABORATORIES, INC. (DLB) FY2026 Q3 P&L / Income Statement

DOLBY LABORATORIES, INC. (DLB) FY2026 Q3 P&L / Income Statement

Income statement for 2026-03-28 through 2026-06-26. View: Product and service (2 categories). Revenue and costs use their disclosed categories.

Total revenue

304,995,000 US dollars

Total cost of revenue

40,319,000 US dollars

Gross profit

264,676,000 US dollars

Total operating expenses

230,360,000 US dollars

Operating income

34,316,000 US dollars

Total other income

9,486,000 US dollars

Income before income taxes

43,802,000 US dollars

Provision for income taxes

14,588,000 US dollars

Net income including noncontrolling interest

29,214,000 US dollars

Licensing revenue

282,351,000 US dollars

Products and services revenue

22,644,000 US dollars

Licensing cost of revenue

22,718,000 US dollars

Products and services cost of revenue

17,601,000 US dollars

Research and development

65,749,000 US dollars

General and administrative

75,585,000 US dollars

Restructuring charges

3,955,000 US dollars

Sales and marketing

85,071,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to DOLBY LABORATORIES, INC.: $28.60 M; to noncontrolling interests: $612.00 K.